Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)
China · Delayed Price · Currency is CNY 63.80
+1.76 (2.84%)
Jul 29, 2025, 3:00 PM CST
Jiangsu Hengrui Medicine Market Cap
Jiangsu Hengrui Medicine has a market cap or net worth of 415.51 billion as of July 29, 2025. Its market cap has increased by 70.75% in one year.
Market Cap
415.51B
Enterprise Value
391.99B
Revenue
29.19B
Ranking
n/a
PE Ratio
56.84
Stock Price
63.80
Market Cap Chart
Since October 20, 2000, Jiangsu Hengrui Medicine's market cap has increased from 2.58B to 415.51B, an increase of 16,026.49%. That is a compound annual growth rate of 22.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 415.51B | 42.37% |
| Dec 31, 2024 | 291.86B | 1.48% |
| Dec 29, 2023 | 287.60B | 17.03% |
| Dec 30, 2022 | 245.74B | -23.94% |
| Dec 31, 2021 | 323.08B | -45.40% |
| Dec 31, 2020 | 591.75B | 53.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 280.39B |
| WuXi AppTec | 253.34B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.97B |
| Sichuan Biokin Pharmaceutical | 122.14B |
| Aier Eye Hospital Group | 121.87B |
| Shanghai United Imaging Healthcare | 112.42B |
| Yunnan Baiyao Group Co.,Ltd | 100.86B |
| Beijing Wantai Biological Pharmacy Enterprise | 75.58B |